IV SECHENOV INTERNATIONAL BIOMEDICAL SUMMIT (SIBS-2020) RESCHEDULED TO NOVEMBER 17-18, 2020... Read more
Scientific Counsellor, Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
Prof. Dr. Tamara Lah Turnšek obtained her PhD in 1981 at the Josef Stefan Institute with a Thesis in the field of protein biochemistry. She was employed there as a research for several period of time with intermediate longer visits abroad, first as post PhD candidate, advancing to Assistant Professor at the Dept. of Pharmacology, Faculty of Medicine at Wayne State University in Detroit. Later on she worked as Visiting Professor and Director of metastasis research at Albert Einstein Medical Center in Philadelphia, Pennsylvania. After that she was committed herself to cancer studies, which she performed at Josef Stefan Institute and later at National institute of biology. From 1995-2018 she was the director of National Institute of Biology, where she established the Department of Genetic Toxicology and Cancer Biology and where she continues to work to this day.
During her early employment as MSci at the Paediatric Clinic, where Tamara Lah investigated hereditary metabolic diseases, she developed an interest for biomedicine and its clinical application. Later on, she cooperated tightly with the Division of Stomatology and Institute of Oncology and is currently collaborating with the Department of Neurosurgery, UKC. Professionally she is interested in biology of tumours (breast, lung, ovarian and brain tumours), but has recently focused on stem cells in relation to cancer in particular in glioblastoma. Besides glioblastoma stem cells, she is interested in mesenchymal stem cells as part of the tumour environment and as therapeutic agents in regenerative medicine and oncology. She performed clinical research of tumour biomarkers with aim of application in prognosis and prediction of the disease and in those respect she was cooperating with pharmaceutical companies in USA (Oncogene Ltd) and Slovenia (KRKA and stil company Lek Sandoz-Novartis. Her recent research has been dedicated to biomarkers of cancer stem cells as new therapeutic target in particular in glioblastoma stem cells. This was the subject of her many international links in Europe, and overseas in USA and Brasil.
Tamara Lah has published about 170 original scientific papers and reviews and 13 contributions to monographs, and many professional and public articles, presentations, interviews, etc.